BEEBE CHERYL K 4
Research Summary
AI-generated summary
Mosaic (MOS) Director Cheryl Beebe Receives RSU Award and Sells Shares
What Happened
Cheryl K. Beebe, a director of Mosaic Co. (MOS), reported vesting/settlement activity on May 28, 2026. The Form 4 shows an award/grant of 7,273 restricted stock units (code A, derivative) and related conversion/exercise entries (code M) that resulted in the acquisition of 2,437 shares and the disposition of 4,873 shares. All transactions are reported at $0.00 per share, indicating these were awards/settlements rather than open-market purchases or sales for cash consideration.
Key Details
- Transaction date: 2026-05-28; Form 4 filed 2026-06-01 (appears timely: filed within required reporting window).
- Reported items and counts: A — 7,273 RSUs (acquired, derivative); M — 2,437 shares acquired (conversion/exercise, $0.00); M — 4,873 shares disposed (conversion/exercise, $0.00).
- Prices/values: All reported at $0.00 (awards/settlements, not market purchases).
- Shares owned after transaction: Not specified in the provided filing summary.
- Footnotes of note:
- F1: The reporting person elected to receive 50% of the restricted stock units in cash with the balance paid in shares at payment.
- F2: One-for-one conversion ratio.
- F3/F5: Some RSUs have different vesting/payment timing references—F5 indicates the RSUs vested on the issuer's 2026 Annual Meeting; F3 references a 2027 meeting for other RSUs.
- F4: Not applicable.
Context
Transaction codes: A = award/grant of restricted stock units; M = exercise or conversion of a derivative/security into shares. Reporting at $0.00 typically means shares came from vested awards or conversion of RSUs rather than a purchase; the filing shows both receipt of award/converted shares and a simultaneous disposition of some shares (often seen when shares are paid out in cash or withheld for tax/administrative purposes). The filing gives factual vesting/settlement details and does not indicate an open-market buy or a discretionary sale for investment purposes.